Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001474064-10-000018)

Filing Details

Accession Number:: 0001474064-10-000018
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-02 13:00:00
Reporting Period:: 2010-02-03

Filing Date:: 2010-04-02
Accepted Time:: 2010-04-02 14:30:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365343	Francois Nader	550 Hills Drive Bedminster NJ 07921	President, Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-02-03	19,350	$3.37	149,658	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was made through an account managed by the Reporting Person's broker, who inadvertently effected the sale of NPS common stock without specific instructions from, and timely notice to, the Reporting Person. Because the Reporting Person was unaware that his NPS common stock had been sold at the time the transaction was effected, he was unable to file a Form 4 reporting the transaction on a timely basis.